Expression of gelatinases was also reported to have an essential role in the invasive capacity of AML and chronic myeloid leukemia, with emerging evidence suggesting that expression of these molecules may be mediated through the FAK/phosphoinositide 3-kinase (PI-3K)/extracellular signal-regulated kinase (ERK) signaling pathways (16,32,33). This evidence concerns the gene PTK2 and acute myeloid leukemia.